Cargando…
Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066064/ https://www.ncbi.nlm.nih.gov/pubmed/36857015 http://dx.doi.org/10.1007/s12012-023-09787-5 |
_version_ | 1785018217962405888 |
---|---|
author | Refaie, Marwa M. M. Rifaai, Rehab Ahmed Fawzy, Michael Atef Shehata, Sayed |
author_facet | Refaie, Marwa M. M. Rifaai, Rehab Ahmed Fawzy, Michael Atef Shehata, Sayed |
author_sort | Refaie, Marwa M. M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10066064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-100660642023-04-02 Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways Refaie, Marwa M. M. Rifaai, Rehab Ahmed Fawzy, Michael Atef Shehata, Sayed Cardiovasc Toxicol Retraction Note Springer US 2023-03-01 2023 /pmc/articles/PMC10066064/ /pubmed/36857015 http://dx.doi.org/10.1007/s12012-023-09787-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Retraction Note Refaie, Marwa M. M. Rifaai, Rehab Ahmed Fawzy, Michael Atef Shehata, Sayed Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways |
title | Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways |
title_full | Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways |
title_fullStr | Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways |
title_full_unstemmed | Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways |
title_short | Retraction Note: Dapagliflozin Guards Against Cadmium-Induced Cardiotoxicity via Modulation of IL6/STAT3 and TLR2/TNFα Signaling Pathways |
title_sort | retraction note: dapagliflozin guards against cadmium-induced cardiotoxicity via modulation of il6/stat3 and tlr2/tnfα signaling pathways |
topic | Retraction Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066064/ https://www.ncbi.nlm.nih.gov/pubmed/36857015 http://dx.doi.org/10.1007/s12012-023-09787-5 |
work_keys_str_mv | AT refaiemarwamm retractionnotedapagliflozinguardsagainstcadmiuminducedcardiotoxicityviamodulationofil6stat3andtlr2tnfasignalingpathways AT rifaairehabahmed retractionnotedapagliflozinguardsagainstcadmiuminducedcardiotoxicityviamodulationofil6stat3andtlr2tnfasignalingpathways AT fawzymichaelatef retractionnotedapagliflozinguardsagainstcadmiuminducedcardiotoxicityviamodulationofil6stat3andtlr2tnfasignalingpathways AT shehatasayed retractionnotedapagliflozinguardsagainstcadmiuminducedcardiotoxicityviamodulationofil6stat3andtlr2tnfasignalingpathways |